Results for enantiomeras translation from Lithuanian to English

duloksetinas vartojamas kaip atskiras enantiomeras.
duloxetine is administered as a single enantiomer.

s-enantiomeras racemizuojasi į r-enantiomerą.
s-enantiomer to the r-enantiomer.

jis yra s-enantiomeras, biokonversija in vivo nerodyta.
ivabradine is the s-enantiomer with no bioconversion demonstrated in vivo.

vartojant terapines dozes (s)-enantiomeras neaptinkamas.
the (s)-enantiomer is not detectable at therapeutic doses.

ropivakainas turi chiralinį centrą ir yra prieinamas kaip grynas s-(-)-enantiomeras.
ropivacaine has a chiral centre and is available as the pure s-(-)-enantiomer.

ikiklinikiniais tyrimais nra nustatyta, kad pregabalino s -enantiomeras racemizuojasi r-enantiomer.
in preclinical studies, there was no indication of racemisation of pregabalin s-enantiomer to the r-enantiomer.

ikiklinikiniais tyrimais nėra nustatyta, kad pregabalino s- enantiomeras racemizuojasi į r-enantiomerą.
in preclinical studies, there was no indication of racemisation of pregabalin s-enantiomer to the r-enantiomer.

(+) enantiomeras labiau slopina prostaglandin sintez, taciau abu enantiomerai yra vienodai stiprs pgf2 antagonistai.
the (+) enantiomer is more potent in inhibiting prostaglandin synthesis.both enantiomers are equipotent pgf2 antagonists.

(+) enantiomeras labiau slopina prostaglandinų sintezę, tačiau abu enantiomerai yra vienodai stiprūs pgf2α antagonistai.
both enantiomers are equipotent pgf2α antagonists.

s( +) enantiomeras blokuoja alfa 2 adrenoreceptorius ir 5- ht2 receptorius, o r (-) enantiomeras − 5- ht3 receptorius.
both enantiomers of mirtazapine are presumed to contribute to the antidepressant activity, the s(+) enantiomer by blocking α 2 and 5-ht2 receptors and the r(-) enantiomer by blocking 5-ht3 receptors.

cas nr.: s-enantiomeras: 173584–44–6 ir r-enantiomeras: 185608–75–7
cas no: s-enantiomer: 173584-44-6 and r-enantiomer: 185608-75-7)

alogliptinas daugiausia egzistuoja kaip (r)-enantiomeras (> 99%) ir in vivo mažai arba visai nevirsta veidrodiniu (s)-enantiomeru.
alogliptin exists predominantly as the (r)-enantiomer (> 99%) and undergoes little or no chiral conversion in vivo to the (s)-enantiomer.

nei levetiracetamo, nei jo pirminio metabolito enantiomerin interkoversija (t. y. vieno enantiomero virtimas kitu) in vivo slygomis neaptikta.
no enantiomeric interconversion was evidenced in vivo for either levetiracetam or its primary metabolite.